Risk of Human Immunodeficiency Virus Type 1—Related Neurologic Disease in a Cohort of Intravenous Drug Users

Archives of Neurology

Volumn 52, Issue 12, 1995, Pages 1174-1182

  Marder, Karen ^a   Liu, Xinhua ^a   Stern, Yaakow ^a   Malouf, Renée ^a   Dooneief, George ^a   Bell, Karen ^a   Todak, George ^a   Joseph, Maryse ^b   Sorrell, Stephen ^b   Sadr, Wafaa ^b   Williams, Janet B W ^b   Ehrhardt, Anke ^b   Stein, Zena ^b   Gorman, Jack ^b  

^a Departments of Neurology ^*  (United States)

^b Departments of Neurology and Psychiatry College of Physicians and Surgeons Gertrude H Sergievsky Center HIV Center for Clinical and Behavioral Studies Division of Epidemiology School of Public Health at Columbia University Harlem Hospital Center St Luke's Roosevelt Hospital Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; COHORT ANALYSIS; DRUG ABUSE; FEMALE; HEAD INJURY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SUBSTANCE ABUSE; VIRUS TRANSMISSION;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; COHORT STUDIES; CRANIOCEREBRAL TRAUMA; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0028791801     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1995.00540360052016     Document Type: Article

References (39)

1. Des Jarlais D, Friedman SR, Choopanya K, Vanichseni S, Ward T. International epidemiology of HIV and AIDS among injecting drug users. AIDS. 1992;6: 1053-1068.
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta, Ga: CDC; October 1993:1-19.
3. O’Connor P, Selwyn P, Schottenfeld R. Medical care for injection-drug users with human immunodeficiency virus infection. N Engl J Med. 1994;331:450-459.
4. Selnes O, McArthur J, Royal W III, et al. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology. 1992;42:1924-1930.
5. McKegney F, O’Dowd M, Feiner C, Selwyn P, Drucker E, Friedland G. A prospective comparison of neuropsychologic function in HIV seropositive and seronegative methadone-maintained patients. AIDS. 1990;4:565-569.
6. Egan V, Brettly R, Goodwin G. The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease. Br J Psychiatry. 1992;161:522-531.
7. Marder K, Stern Y, Malouf R, et al. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome: relationship to head injury. Arch Neurol. 1992;49:1169-1175.
8. El-Sadr W, Goetz R, Sorrell S, Joseph M, Ehrhardt A, Gorman J. Clinical and laboratory correlates of human immunodeficiency virus infection in a cohort of intravenous drug users from New York, NY. Arch Intern Med. 1992;152: 1653-1659.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
10. Centers for Disease Control. CDC classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep. 1986;35:334-339.
11. Gorman JM, Kertzner R, Todak G, et al. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection, I: overview of study design. Arch Gen Psychiatry. 1991;48:120-123.
12. Fahn S, Marsden C, Calne D, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987;2:153-163.
13. Price RW, Brew B, Sidtis J, Rosenblum M, Sheck A, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988;239:586-592.
14. Marder K, Liu X, Stern Y, et al. Neurologic signs and symptoms in a cohort of gay men followed for 4.5 years. Neurology. 1995;45:261-266.
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444-1452.
16. Stern Y, Marder K, Bell K, et al. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection, III: neurologic and neuropsychologic findings. Arch Gen Psychiatry. 1991;48:131-138.
17. Stern Y, Liu X, Marder K, et al. Neuropsychological changes in a prospectively followed cohort of gay and bisexual men with and without HIV. Neurology. 1995;45:467-472.
18. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24:1019-1025.
19. Klove H. Clinical neuropsychology. Med Clin North Am. 1963;46:1647-1658.
20. Tuokko H, Vernon-Wilkinson RR, Weir J, Beattie BL. Cued recall and early identification of dementia. J Clin Exp Neuropsychol. 1991;13:871-879.
21. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-276.
22. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia, Pa: Lea & Febiger; 1983.
23. Wechsler D. Wechsler Adult Intelligence Scale Revised. New York, NY: The Psychological Corp; 1981.
24. Sano M, Rosen W, Mayeux R. Attention deficits in Alzheimer's disease. Presented at the American Psychological Association 1984. (Abstract).
25. Folstein MF, Folstein SE, McHugh PR. ’Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
26. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
27. Weber R, Band L, de Costa B, et al. Neural control of immune function: opioids, opioid receptors, and immunosuppression. In: Harris L, ed. Problems of Drug Dependence 1990. Rockville, Md: National Institute on Drug Abuse; 1991; 96. US Dept of Health and Human Services research monograph 105.
28. Paik M, Begg M, El-Sadr W, Gorman J, Stein Z. Difference in clinical implications of CD4 counts among HIV-infected homosexual men, injection drug using men and women. Stat Med. In press.
29. Langston J, Ballard P, Tetrud J, Irwin L. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979.
30. Cardoso F, Jankovic J. Movement disorders. Neurol Comp Drug Alcohol Abuse. 1993;11:625-638.
31. Dal Pan G, McArthur J, Aylward E, et al. Patterns of cerebral atrophy in HIV-1 infected individuals: results of a quantitative MRI analysis. Neurology. 1992; 42:2125-2130.
32. Aylward E, Henderer J, McArthur J, et al. Reduced basal ganglia volume in HIV-1 associated dementia: results from quantitative neuroimaging. Neurology. 1993;43:2099-2104.
33. Dooneief G, Bello J, Todak G, et al. A prospective controlled study of magnetic resonance imaging of the brain in gay men and parenteral drug users with human immunodeficiency virus infection. Arch Neurol. 1992;49:38-43.
34. McArthur JC, Cohen B, Selnes O, et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: results from the Multicenter AIDS Cohort Study. Ann Neurol. 1989;26: 601-611.
35. Michaels J, Sharer L, Epstein L. Human immunodeficiency virus type-1 (HIV-1) infection of the nervous system: a review. Immunodefic Rev. 1988;1: 71-104.
36. Navia B, Cho E, Petito C, Price R. The AIDS dementia complex, II: neuropathology. Ann Neurol. 1986;19:523-535.
37. Lipton S, Sucher N, Kaiser P, Dreyer E. Synergistic effects of the HIV coat protein and NMDA receptor—mediated neurotoxicity. Neuron. 1991;7:111-118.
38. Heyes M, Brew B, Martin A, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991;29:202-209.
39. Bacellar H, Munoz A, Miller E, et al. Temporal trends in the incidence of HIV-1 related neurologic diseases: multicenter AIDS cohort study, 1985-1992. Neurology. 1994;44:1892-1900.